Back to User profile » Dr Tadahiko Shien

Paper published by Dr Tadahiko Shien:


Open-label Phase II study of everolimus plus endocrine therapy in postmenopausal women with ER-positive and HER2-negative metastatic breast cancer (Chloe trial)

Shimoi T, Shimomura A, Shien T, Uemura Y, Kato H, Kitada M, Toyama T, Aihara T, Mukai H

Open Access Journal of Clinical Trials 2018, 10:13-18

Published Date: 16 February 2018